UFP Technologies (UFPT) Q2 2026 earnings — TrendMatrix coverage

Adjusted EPS

$2.92

Estimate

$2.56

Surprise

+14.2%

Score at report (before → after)

5.1 → 5.1/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

UFP Technologies (UFPT) beat the $2.56 estimate with adjusted EPS of $2.92 — a large 14.2% upside surprise. TrendMatrix's engine moved from Hold (5.1/10) to Sell at 5.1/10 after the report.

TrendMatrix currently rates UFPT Hold at 5.7/10.

4 of the last 4 quarters beat the estimate; this quarter's +14.2% surprise compares with a +10.2% four-quarter average. Next scheduled report: 2026-11-02.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$285.20

Price target

$301.75

Stop

$269.46

Upside to target

+5.8%

Reward-to-risk

1.1:1

Model outputs from TrendMatrix’s engine as of 2026-09-23 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Medical Devices

Market cap

$2.21B

P/E (fwd)

24.0

P/E (ttm)

30.9

52-week range

$173.86–$338.71

Off 52-week high

15.8%

RSI (14)

39

Volume vs avg

0.78×

Score today

5.7/10